glp-1 sleep apnea trial Certain Patients Benefit Most from for Apnea, Obesity Therapeutic Potential of Glucagon-like Peptide-1
Description
Clinical Trial Registration EudraCT number, 2015-005585-32
95% CI 1.09 to 2.12
"The thing that concerns me the most with these drugs
Objective: Affected by aging, the elderly diabetes patients have many pathological characteristics different from the young people, including more complicati...
Signaling Details: Suppress pro-inflammatory cytokines, upregulate anti-inflammatory cytokines and shift macrophages to an M2 (healing) phenotype
Free sign up:
